Antisense Therapeutics Ltd
ASX:ANP

Watchlist Manager
Antisense Therapeutics Ltd Logo
Antisense Therapeutics Ltd
ASX:ANP
Watchlist
Price: 0.084 AUD 1.2% Market Closed
Market Cap: 75.7m AUD

Net Margin
Antisense Therapeutics Ltd

-2 956.4%
Current
-66 097.1%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2 956.4%
=
Net Income
-11.4m
/
Revenue
384.9k

Net Margin Across Competitors

No Stocks Found

Antisense Therapeutics Ltd
Glance View

Market Cap
75.7m AUD
Industry
Pharmaceuticals

Antisense Therapeutics Ltd. engages in the research and development of novel antisense pharmacceuticals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-12-20. The firm is engaged in developing and commercializing antisense pharmaceuticals for unmet markets in rare diseases. The firm's product candidate, ATL1103, is an antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-I (IGF-I) in the blood. ATL1103 is in clinical development for acromegaly. The firm's product candidate, ATL1102, is an antisense inhibitor targeting very late antigen 4 (VLA-4), an immune cell molecule. The firm completed a Phase IIa efficacy and safety trial of ATL1102 in multiple sclerosis (MS) patients. The firm is engaged in clinical development of ATL1102 in patients with Duchenne Muscular Dystrophy (DMD). The firm is conducting a Phase II clinical trial of ATL1102 in DMD patients.

ANP Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2 956.4%
=
Net Income
-11.4m
/
Revenue
384.9k
What is the Net Margin of Antisense Therapeutics Ltd?

Based on Antisense Therapeutics Ltd's most recent financial statements, the company has Net Margin of -2 956.4%.

Back to Top